SCHEMBL14243294

SCHEMBL14243294

CC(Nc1cc(NC2CC2)n2ncc(/C=C(\NC=O)C(N)=O)c2n1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK2B P67870 5/20 0.45
CSNK2A2 P19784 6/20 0.37
CSNK2A1 P68400 4/20 0.37
TYK2 P29597 2/20 0.36
NTRK1 P04629 2/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
PLK1 P53350 1/20 0.36
CDK2 P24941 2/20 0.35
NUDT1 P36639 1/20 0.35
KCNH2 Q12809 2/20 0.34
MAPK1 P28482 1/20 0.34
NR2F2 P24468 1/20 0.34
DYRK3 O43781 1/20 0.34
GSK3B P49841 1/20 0.34
PIM3 Q86V86 1/20 0.34
HIPK2 Q9H2X6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14242544 0.81 CSNK2B (0.51) CSNK2BCSNK2A2CSNK2A1TYK2CDK2
SCHEMBL14243301 0.80 CSNK2B (0.48) CSNK2BCSNK2A2CSNK2A1TYK2CDK2
SCHEMBL14243124 0.80 CSNK2B (0.48) CSNK2BCSNK2A2CSNK2A1TYK2MEN1
SCHEMBL14242539 0.79 CSNK2B (0.44) CSNK2BCSNK2A2CSNK2A1TYK2MEN1
SCHEMBL14242464 0.77 CSNK2B (0.44) CSNK2BCSNK2A2CSNK2A1TYK2MEN1
SCHEMBL12830563 0.76 CSNK2B (0.44) CSNK2BCSNK2A2CSNK2A1TYK2MEN1
SCHEMBL14242893 0.76 CSNK2B (0.40) CSNK2BCSNK2A2CSNK2A1TYK2NTRK1
SCHEMBL14242596 0.76 CSNK2B (0.40) CSNK2BCSNK2A2CSNK2A1TYK2CDK2
SCHEMBL12645312 0.75 CSNK2B (0.44) CSNK2BCSNK2A2CSNK2A1TYK2NTRK1
SCHEMBL12645528 0.75 CSNK2B (0.44) CSNK2BCSNK2A2CSNK2A1TYK2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012170827-A2 PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2012-12-13 WO disclosed